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Abstract: Previously unknown 3,4-diamino-1,2,5-selenadiazole 6 
was prepared by hydrolysis of [1,2,5]selenadiazolo[3,4-
c][1,2,5]selenadiazole 7b and used in synthesis of novel 1,2,5-
selenadiazolo[3,4-b]pyrazines by the Koerner-Hinsberg reaction 
covering the parent compound 4 and its substituted derivatives 5a-g. 
The compounds synthesized were characterized by solution and 
solid-state 
77
Se NMR, and 6, 5-Ph and 5,6-
Me2[1,2,5]selenadiazolo[3,4-b]pyrazines (5a,g, respectively) by X-
ray diffraction. Electrochemical reduction of 5,6-
R2[1,2,5]selenadiazolo[3,4-b]pyrazines 5c,g (R = Ph, Me) into novel 
persistent radical anions (RAs) was studied by cyclic voltammetry 




 were characterized by EPR 
spectroscopy combined with DFT calculations. 
Introduction 
The chemistry of chalcogen-nitrogen π-heterocycles, 
particularly 1,2,5-chalcogenadiazoles, is an important part of 
contemporary organic and organoelement chemistry and its 
applications in the field of biomedicine and molecule-based 
functional materials.[1-9] Amongst 1,2,5-chalcogenadiazoles the 
best studied are the sulfur derivatives[1-4,7,10,11] though there are 
scattered reports on the selenium analogues,[2,4,7,12-14] whereas 
chemistry of 1,2,5-telluradiazoles is only emerging.[4-7,15,16] Very 
recent interest to these compounds, especially fused with 
benzene and heterocyclic rings, is due to their actual or potential 
applications as building blocks in organic functional materials 
such as light emitters, solar cells, synthetic metals, as well as 
drugs for preventive and therapeutic medical treatment and 
fluorescent imagine probes.[1,4,7,13,14,17] 
Recently, it was shown that many classes of chalcogen-
nitrogen π-heterocycles possess positive electron affinity (EA) 
making them suitable precursors for thermodynamically stable 
radical anions (RAs) which are possible building blocks for 
magnetically-active functional materials.[7-9] Whereas some 
1,2,5-thiadiazolidyl RAs, including [1,2,5]thiadiazolo[3,4-
b]pyrazinidyl, have already been isolated in the form of thermally 
stable salts,[7-9,18] investigation of their Se congeners is restricted 
by synthetic accessibility. There is a lack of suitable preparative 
approaches to many interesting and potentially useful 
derivatives with enlarged EA including, for example, 
[1,2,5]selenadiazolo[3,4-b]pyrazines. 
In principle, these compounds could be prepared from 2,3-
diaminopyrazines[19] and SeO2, i.e. using the standard Hinsberg 
approach to the selenadiazole ring-closure..[2,4,13,14] The diamines, 
however, are relatively hardly accessible, and in this work two 
synthetic alternatives conceptually based on the Yuryev[17] and 
the Koerner-Hinsberg[20] reactions were investigated. The first 
reaction deals with heteroatom exchange in five-membered 
heterocycles, and the second with pyrazine ring-closure. 
This paper describes the synthesis of previously unknown 
3,4-diamino-1,2,5-selenadiazole and its use in the synthesis 
of the title compounds under conditions of the Koerner-
Hinsberg reaction. The key diamine and the 
[1,2,5]selenadiazolo[3,4-b]pyrazines synthesized were 
characterized by multinuclear NMR including solution and 
solid-state 77Se NMR and X-ray diffraction (XRD). The 
[1,2,5]selenadiazolo[3,4-b]pyrazines were used for 
electrochemical generation of their radical anions and the 
novel persistent RAs obtained were characterized by EPR in 
combination with DFT calculations. 
Results and Discussion 
2.1. Synthesis 
Recently, the first representative of the heterocycles under 
discussion, i.e. [1,2,5]selenadiazolo[3,4-b]quinoxaline 1, was 
obtained by direct exchange of the sulfur atom of the 
corresponding 1,2,5-thiadiazole 2 by a selenium atom (Scheme 
1).[12] 
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Scheme 1. Synthesis of [1,2,5]selenadiazolo[3,4-b]quinoxaline 1 from the 
corresponding thiadiazole 2. 
To explore the synthetic scope of the direct transformation of 
1,2,5-thiadiazoles into 1,2,5-selenadiazoles, the reaction 
between [1,2,5]thiadiazolo[3,4-b]pyrazine 3 and SeO2 was 
studied. It was found that heating 3 with SeO2 (1.2 equiv) at 
100 °C in dimethylformamide (DMF) gives 
[1,2,5]selenadiazolo[3,4-b]pyrazine 4 in low yield (Scheme 2) 
together with several byproducts. Attempts to purify 4 by 
crystallization were unsuccessful due to its instability in DMF 
and other organic solvents on heating. 
 
Scheme 2. Synthesis of [1,2,5]selenadiazolo[3,4-b]pyrazine 4 from 
[1,2,5]thiadiazolo[3,4-b]pyrazine 3 and SeO2. 
Retrosynthetic analysis suggested that the reliable precursor 
of the parent [1,2,5]thiadiazolo[3,4-b]pyrazine 4 and its 
substituted derivatives 5 would be the previously unknown 3,4-
diamino-1,2,5-selenadiazole 6 (Scheme 3) which can be 
prepared from [1,2,5]thiadiazolo[3,4-c][1,2,5]selenadiazole 7a or 
its selenium counterpart 7b.[12] 
 
Scheme 3. Retrosynthetic route for the [1,2,5]selenadiazolo[3,4-b]pyrazines 
preparation. 
1,2,5-Thia/selenadiazoles are a well-known protected form 
of 1,2-diamines. Normally, the diamines can be recovered by 
reduction of the heterocycles[21-23] and in some cases also by 
hydrolysis. In this work, technically simple hydrolysis was 
employed. 
Treatment of 7a with 3M ammonium hydroxide solution at 
room temperature gave no reaction whereas refluxing of the 
reaction for 0.5 h led to a mixture of 3,4-diamino-1,2,5-
selenadiazole 6 and 3,4-diamino-1,2,5-thiadiazole 8 in 
practically 1 : 1 ratio (Scheme 4) suggesting that the hydrolysis 
rates of the thia- and selenadiazole rings of 7a are similar under 
the conditions used. 
 
Scheme 4. Hydrolysis of [1,2,5]thiadiazolo[3,4-c][1,2,5]selenadiazole 7a. 
However, 7b was easily hydrolyzed with 3M ammonium 
hydroxide solution to give the target compound 6 in high yield 
(Scheme 5). The structure of 6 was confirmed by XRD (section 
2.2). 
 
Scheme 5. Synthesis of 3,4-diamino-1,2,5-selenadiazole 6. 
Compound 6 was used in synthesis of the title compounds 
by the Koerner-Hinsberg reaction. With glyoxal (40% water 
solution), it was found that the yield of the parent 
selenadiazolopyrazine 4 depends strongly upon the solvent 
used. Refluxing in methanol and heating in ethanol at 60-65°С 
for 3 h gave 4 in moderate yields (53 and 51 %, respectively). 
Using the same reagents in glacial acetic acid for 1 h at room 
temperature increased the yield of 4 to 79% (Scheme 6). 
 
Scheme 6. Synthesis of the parent [1,2,5]selenadiazolo[3,4-b]pyrazine 4. 
Under the same conditions, the reaction was extended to 
other 1,2-diketones including fused systems with aromatic 
groups. With phenylglyoxal (a) and ninhydrine (b), the reaction 
proceeded at room temperature, though with benzyl (c), 
phenanthren-9,10-dione (d) and acenaphthylen-1,2-dione (e) 
refluxing in acetic acid for 3 h was required. Target products 5a-
e were obtained in moderate to high yields (Scheme 7). The 
structure of 5a was confirmed by XRD (section 2.2). 







Scheme 7. Synthesis of the [1,2,5]selenadiazolo[3,4-b]pyrazines 5a-e. 
It was found that 2-oxopropanal and diacetyl were decomposed 
in acetic acid, and their reaction with 6 led to complex mixtures 
with no significant amount of desired compounds 5. Changing 
the solvent to ethanol gave better results and treatment of 6 with 
these diketones at room temperature for 12 h afforded 
derivatives 5f,g in good yields (Scheme 8). The structure of 5g 
was confirmed by XRD (section 2.2). 
 
Scheme 8. Synthesis of the substituted [1,2,5]selenadiazolo[3,4-b]pyrazines 
5f,g. 
2.2. Structure elucidation by XRD and 
77
Se NMR 
The authenticity of the compounds synthesized was 
confirmed by solution 1H, 13C and 77Se NMR and XRD, and for 
insoluble compounds by solid-state 77Se NMR. 
 
Figure 1. ORTEP plot of 6 showing 50% probability ellipsoids (left) and 
fragment of a homochiral H-bonded chain in its crystal (right). 
According to XRD (Figures 1 and 2), geometries of the 
selenadiazole rings of 6 and 5a,g are quite similar. For 6 (Figure 
1), the geometry of the selenadiazole moiety is similar to that 
reported for 3,4-R2-1,2,5-selenadiazoles (9a, R = Ph
[24]; 9b, R = 
CN[25]). In 5a,g, the Se-N (1.786 and 1.806 Å), C-N (1.321 and 
1.327 Å) and C-C (1.436 Å) distances have typical values and 
are statistically indistinguishable in the two compounds. In 5a, 
the Ph substituent is slightly twisted out of the mean plane of the 
main ring with the torsion angle being 10.2o. In 5g, the Me 
groups lie slightly above and below the mean plane of the ring, 








































Figure 2. Left: ORTEP plots of 5a (above) and 5g (below) showing 50% 
probability ellipsoids. Right: Corresponding packing patterns. 
In the solid state, 1,2,5-selenadiazoles normally reveal 
propensity to secondary bonding interactions Se…N. Those lead 
to 1-3 dimensional architectures via the formation of the 
[Se…N]2 four-membered rings. The architectures are of current 
interest for supramolecular chemistry and crystal 
engineering.[26,27] 
In 6, the presence of two NH2 groups results in an extensive 
H-bonded network in the crystals. The strongest N-H…N bond 
(N…N 3.035 Å, NHN 171°) assembles the molecules into  






Figure 3. CP MAS 
77
Se NMR spectra of 5f (above) and 5e (below) with 
isotropic resonances indicated by asterisks. 
homochiral infinite chains (Figure 1) that interconnect via weaker 
N-H…N bonds (N…N 3.189–3.278 Å, NHN 128–173°) to give a 
non-centrosymmetric crystal packing (space group P212121). 
There are also shortened Se…Se (3.319 Å) and Se…N (3.129 
Å) contacts. In the case of 9a these interactions give rise to 
centrosymmetric dimers (space group P21/c), while with 9b they 
result in homochiral chains (space group P212121). 
In 5a, the molecules pack the crystal in slipped herringbone 
fashion and these tow stacks are linked by Se...N interactions 
(3.022 Å) and weak N…H contacts (2.49 Å), as well as edge to 
face interactions of the phenyl rings. In 5g, the molecules pack 
in parallel stacks along the c axis, the pyrazine rings lying 
approximately above and below each other in both stacks, with 
lateral contacts Se…N (3.264 Å) connecting the sheets (Figure 
2). Overall, the main packing motifs are rather different in 6 and 
5a,h. 
Cross-polarization magic angle spinning (CP MAS) 77Se 
solid-state NMR spectra were measured for compounds 5e,f. 
As shown in Figure 3, a single Se site was observed in both 
cases, consistent with the molecular symmetry, at iso 1449 for 
5e and 1454 for 5f. The manifold of spinning sidebands 
confirms the presence of a significant chemical shift anisotropy 
in each molecule. 
The solid-state δ77Se for compounds 5e,f agree well with 
those measured in solution for compounds 5a-c,g (δ77Se, 1425-
1470; Experimental). A whole set of obtained data is in 
accordance with the results of previous studies on similar Se-N 
heterocycles including 2,1,3-benzoselenadiazoles and their 
polyfluorinated derivatives.[12,21,28,29] For compound 6, δ77Se is 
1315 thus highlighting deshielding effect of electron-withdrawing 
pyrazine ring in derivatives 5. 
 
2.3. Electrochemical properties and radical anions 
Figure 4. CV of 5g (above) and 5c (below) in MeCN. 
 
Derivatives 5c and 5g were selected for evaluation of the 






















































Figure 5. Experimental and simulated EPR spectra of RA [5g]
–
. 
According to the gas-phase (U)B3LYP/6-31+G(d) 
calculations, the first adiabatic electron affinity (EA) of 
compounds 5g and 5c are 1.55 and 1.93 eV, respectively, as 
compared with 0.22 eV for 1,2,5-selenadiazole and 1.06 eV for 
2,1,3-benzoselenadiazole (10).[7] 
In the potential range 0 – –2 V, the cyclic voltammogram 
(CV) of 5g contains three reduction peaks Ep
1C = –0.98, Ep
2C = –
1.67 and Ep
3C = –1.96 V, and that of 5c two reduction peaks Ep
1C 
= –0.75 and Ep
2C = –1.49 V (Figure 4). For comparison, for 10 
Ep
1C = −1.40 V.[30] For both 5g and 5c the first reduction peak is 





1C = 0.06 V), i.e. corresponding to the 
formation of RAs [5g]– and [5c]–, respectively. For both 
compounds the first reduction peaks are reversible even at slow 
potential sweep rates of 0.01 V.s–1 thus revealing relative 
stability of RAs [5g]– and [5c]–. Thus, according to both CV and 








































Table 1. Experimental / calculated
[a]



















 0.413 / 0.401 0.228 / 0.291 0.319 / 0.317 
[5c]
–
 0.387 / 0.358 0.258 / 0.320 – 
[c]
 / 0.044, 0.040, 0.028,  
0.021, 0.010 
[a] UB3LYP/6-31+G(d). [b] 6H. [c] Not determined by simulation. 
 
Electrochemical generations of RAs [5g]– and [5c]– for EPR 
measurements were performed in the temperature range 295–  
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Figure 7. Top to bottom: Mulliken atomic charges, atomic spin densities, π*-SOMOs and spin density distributions on the VdW surfaces of RAs [5g]
–
 (left) and 
[5c]
–
 (right) from the UB3LYP/6-31+G(d) calculations. Color code: S – yellow, N – blue, C – grey, H – light grey. 






220 К with quartz tube in the resonator shifting the spectra 
downfield by 145–150 G (14.5–15 mT). At 295 K, EPR spectra 
of only moderate quality were obtained for both RAs. Examples 
of low-temperature experimental spectra together with simulated 
ones are shown in Figures 5 and 6 for RAs [5g]– and [5c]–, 
respectively, and the experimental and DFT-calculated hfc 
constants are given in Table 1. Figure 7 shows Mulliken atomic 
charges, atomic spin densities, π*-SOMOs and spin density 
distribution on the van der Waals (VdW) surfaces of RAs [5g]– 
and [5c]– from the UB3LYP/6-31+G(d) calculations. As follows 
from the calculations, the π*-SOMO in both cases is essentially 
antibonding. The spin density on the VdW surfaces of both RAs 
is mostly positive featuring negative values only in the area of 
C3a-C7a bond. 
We anticipate that the stability of the RAs [5c]– and [5g]– 
under the CV conditions will lead to the eventual isolation of 
[1,2,5]selenadiazolo[3,4-b]pyrazinidyls in the form of salts after 
their chemical generation (cf. ref. 18), and this will be a direction 
of our further work. Due to the spin polarization of RAs (Figure 
7), within the McConnell I model antiferromagnetic effects 
should be expected for their homospin salts where only RA is 
paramagnetic. For ferromagnetic effects, heterospin salts are 
required where both ions are paramagnetic with cations 
featuring negative spin density on their VdW surfaces.[7-9] 
Conclusions 
A convenient route to the previously unknown 3,4-diamino-1,2,5-
selenadizole 6 has been developed. Compound 6 is promising 
starting material for variety of organic syntheses. In this work, 
novel [1,2,5]selenadiazolo[3,4-b]pyrazines including the parent 
compound 4 and its substituted derivatives 5a-g have been 
prepared from 6 and 1,2-diketones by the Koerner-Hinsberg 
reaction. The compounds synthesized have been characterized 
by XRD and multinuclear NMR including 77Se solid-state NMR. 
According to the DFT calculations, [1,2,5]selenadiazolo[3,4-
b]pyrazines obtained possess positive EA. They are precursors 
of novel persistent RAs under CV conditions. The identity of the 
electrochemically generated RAs has been confirmed by EPR 
spectroscopy in combination with DFT calculations. Stability of 
[1,2,5]selenadiazolo[3,4-b]pyrazinidyls under the CV conditions 
motivates experiments towards their eventual isolation in the 
form of magnetically-active salts after chemical generation. 
Experimental Section 
General: Elemental analyses for C, H and N were performed with 
Perkin Elmer 2400 Elemental Analyser, analyses for Se by 
spectrophotometric method described in ref. 31. Melting points were 
determined on a Kofler hot-stage apparatus and are uncorrected. 
Solution 1H (300.1 MHz), 13C (75.5 MHz) and 77Se (76.3 MHz) NMR 
spectra were taken for CDCl3 solutions (unless otherwise indicated) 
with a Bruker AM-300 machine and referred to TMS (1H and 13C) and 
(CH3)2Se (
77Se), J values are given in Hz. CP MAS 77Se solid-state 
NMR experiments were performed at 298 K using a Bruker Avance III 
spectrometer operating at a magnetic field strength of 9.4 T 
corresponding to a 77Se Larmor frequency of 76.3 MHz. Experiments 
were carried out using conventional 4 mm MAS probes and with MAS 
rates between 5 and 12.5 kHz. Chemical shifts are referenced relative to 
(CH3)2Se at 0 ppm, using the isotropic resonance of solid H2SeO3 at 
1288.1 ppm as a secondary reference. For all samples transverse 
magnetization was obtained by cross polarization from 1H using 
optimized contact pulse durations of 40 ms, and two-pulse phase 
modulation 1H decoupling during acquisition. Spectra were acquired with 
recycle intervals of between 5 and 55 s, depending on the longitudinal 
relaxation time of the samples. The positions of the isotropic resonances 
within the spinning sidebands patterns were unambiguously determined 
by recording a second spectrum at a higher MAS rate. MS spectra (EI, 
70 eV) were obtained with a Finnigan MAT INCOS 50 instrument. 
High-resolution MS spectra were measured on a Bruker micrOTOF II 
instrument using electrospray ionization (ESI). The measurements were 
operated in a positive ion mode (interface capillary voltage –4500 V) or in 
a negative ion mode (3200 V); mass range was from m/z 50 to m/z 3000 
Da; external or internal calibration was done with Electrospray Calibrant 
Solution (Fluka). A syringe injection was used for solutions in acetonitrile, 
methanol, or water (flow rate 3 L.min–1). Nitrogen was applied as a dry 
gas; interface temperature was set at 180°C. IR spectra were measured 
with a Specord M-80 instrument in KBr pellets. CV measurements on 
solution of compounds 5c,g in dry MeCN (C = 2 × 10–3 М) were 
performed at 298 K in an argon atmosphere with a PG 310 USB 
potentiostat (HEKA Elektronik). A spherical platinum electrode (S = 0.08 
cm2) was used. The supporting electrolyte was 0.1 M Et4NClO4. The 
sweep rates were v = 0.01–1.0 V.s–1. Peak potentials were quoted with 
reference to a saturated calomel electrode (SCE). EPR measurements 
on electrochemically generated RAs [5c]– and [5g]– (C = 2 mM in MeCN) 
were carried out with a ELEXSYS-II E500/540 spectrometer (MW power 
10 mW, modulation frequency 100 kHz and modulation amplitude 0.005 
mT) using a standard cell with platinum working electrode for EPR 
measurements under anaerobic conditions. Simulations of the 
experimental EPR spectra were performed with the Winsim 2002 
program[32] using the Simplex algorithm for many-parameter optimization 
of hfc values and line widths. The accuracy of calculating the hfc values 
was 0.001 mT. DFT calculations were performed at the (U)B3LYP/6-
31+G(d) level of theory with full geometry optimization with the Gaussian-
09 program package.[33] [1,2,5]Selenadiazolo[3,4-c][1,2,5]selenadiazole 
7b was prepared according to the published procedure.[12] 
X-ray diffraction: Crystal data for 5a: C10H5N4Se, Mr = 260.14 g mol
–1, 
monoclinic, space group P21/c, a = 14.661(3), b = 5.7089(9), c = 
11.488(2) Å,  = 107.427(5), V = 917.4(3) Å3, Z = 4, ρcalc = 1.883 g m
–3, μ 
= 40.59 mm–1, F(000) = 508. Rigaku XRF generator, ((MoK) = 0.71072 
Å), Dectris P200 detector, T = 173 K, 9396 reflections, 1680 independent 
reflections (Rint = 0.0361). wR2 = 0.0788 and GOF = 0.892 for all 
independent reflections (R1= 0.0223 was calculated against F for 1515 
observed reflections with I > 2(I)). All calculations were performed using 
SHELXL.[34] 
Crystal data for 5g: C6H6N4Se, Mr = 213.13 g mol
–1, monoclinic, space 
group P21/c, a = 12.105(8), b = 9.012(5), c = 6.811(4) Å,  = 
100.059(19)o, V = 731.6(8) Å3, Z = 4, ρcalc = 1.935 g m
–3, μ = 50.65 mm–1, 
F(000) = 416. Rigaku MMoo7 generator, ((MoK) = 0.71072 Å), Saturn 
724 detector, T = 125 K, 9119 reflections, 1328 independent reflections 
(Rint = 0.1008). wR2 = 0.2133 and GOF = 1.153 for all independent 
reflections (R1= 0.0776 was calculated against F for 1023 observed 
reflections with I > 2(I)). All calculations were performed using 
SHELXL.[34] 
Crystal data for 6: C2H4N4Se, Mr = 163.05 g mol
–1, orthorhombic, space 
group P212121, a = 3.93580(10), b = 8.8682(3), c = 12.8796(4) Å, V = 
449.54(2) Å3, Z = 4 (Z’ = 1), ρcalc = 2.409 g m
–3, μ = 81.98 mm–1, F(000) = 






312. Intensities of 9009 reflections were measured with a Bruker APEXII 
CCD diffractometer ((MoK) = 0.71072 Å, -scans,   58), and 1195 
independent reflections (Rint = 0.0215) were used in further refinement. 
The structure was solved by direct method and refined by the full-matrix 
least-squares technique against F2 in the anisotropic-isotropic 
approximation. Hydrogen atom positions were found in difference Fourier 
synthesis and refined in the isotropic approximation within the riding 
model. The refinement converged to wR2 = 0.0322 and GOF = 1.002 for 
all independent reflections (R1= 0.0119 was calculated against F for 
1177 observed reflections with I > 2(I)). All calculations were performed 
using SHELXTL PLUS 5.0.[34] 
CCDC 1401703, 1401704 and 1045610 contain the supplementary 
crystallographic data for 5a, 5g and 6, respectively. These data can be 
obtained free of charge via 
http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 
Union Road, Cambridge, CB21EZ, UK; fax: (+44) 1223-336033; or 
deposit@ccdc.cam.ac.uk. 
3,4-Diamino-1,2,5-selenadiazole 6: A mixture of compound 7b (141 mg, 
0.58 mmol) and a solution of NH4OH in water (3М, 2.2 ml) was stirred at 
room temperature for 1 h. The reaction mixture was extracted with EtOAc 
(4×5 ml), washed with brine (3×10 ml) and evaporated under reduced 
pressure. Colorless solid, yield 0.90 g (61%). mp = 177-179ºС. Anal. 
calcd for С2Н4N4Se (163.04): С 14.73, Н 2.47, N 34.36. Found: C 14.52, 
H 2.32, N 34.65. NMR, δ, 1H: 6.36 (s, 4Н, 2NH2); 
13С: 153.0; 77Se: 1315. 
IR, ν, cm–1: 3420, 3278 and 3155 (NH), 1618 (C=N), 1514, 1418, 702. 
MS, m/z (%): 166 (M+2, 16), 164 (M+, 100), 162 (50), 160 (20), 124 (16), 
122 (90), 120 (45), 80 (33), 42 (30). ESI-MS: found m/z 164.9667; calc. 
for С2Н5N4Se [M+H]
+ 164.9674. 
General procedure for the reaction of 3,4-diamino-1,2,5-
selenadiazole 6 with 1,2-diketones in acetic acid: A mixture of 
compound 6 (49 mg, 0.3 mmol) and 1,2-diketone (0.33 ммоль) in AcOH 
(3 ml) was stirred at room temperature for 12 h or heated under reflux for 
3 h and cooled to room temperature. Precipitate was filtered off, washed 
by ether and dried. 
[1,2,5]Selenadiazolo[3,4-b]pyrazine 4. Pale grey solid, yield 28 mg 
(61%), mp > 300°С. Anal. calcd for С4Н2N4Se (185.05): С 25.96, Н 1.09, 
N 30.28. Found: C 25.72, H 1.01, N 30.58.  NMR (DMSO-d6), δ, 
13С: 
148.5, 150.8. IR, ν, cm–1: 1479, 1395, 1254, 1168, 1008, 880, 742, 692, 
521, 469. MS, m/z (%): 186 (M+, 100), 184 (34), 107 (11), 105 (7), 80 




5-Phenyl[1,2,5]selenadiazolo[3,4-b]pyrazine 5a. Yellow solid, yield 60 
mg (77%), mp 219-221°С. Anal. calcd for С10Н6N4Se (185.05): С 45.99, 
Н 2.32, N 21.45. Found: C 46.14, H 2.45, N 21.21. NMR (DMSO-d6), δ, 
1H: 7.64 (m, 3Н, Ph), 8.41 (m, 2Н, Ph), 9.73 (s, 1Н, CH); 13С: 128.8, 
129.8, 132.1, 135.5, 149.8, 155.2, 156.7, 157.3; 77Se: 1462. IR, ν, cm–1: 
3062 (CH), 1552, 1482, 1274, 1215, 1030, 957, 771, 687, 507, 479. MS, 
m/z (%): 264 (M+2, 17), 262 (M+, 70), 260 (61), 185 (1), 183 (27), 181 (4), 
131 (7), 129 (52), 105 (15), 103 (51), 101 (11), 79 (21), 77 (11). ESI-MS: 
found m/z 284.9659; calc. for C10Н6N4
78Se [M+Na]
+ 284.9650. 
9Н-Inden[1,2-e][1,2,5]selenadiazolo[3,4-b]pyrazin-9-one 5b. Yellow 
solid, yield 75 мг (87%), mp 347-349°С. Anal. calcd for С11Н4N4OSe 
(287.14): С 46.01, Н 1.40, N 19.51. Found: C 46.23, H 1.11, N 19.29. 
NMR (DMSO-d6), δ, 
1H: 7.82 (d, 1Н, Ar; J = 6.0), 7.98 (m, 2Н, Ar), 8.22 
(d, 1Н, Ar; J = 6.0); 13С: 123.8, 124.8, 134.7, 138.0, 139.7, 140.6, 155.8, 
157.7, 157.8, 160.0, 188.1 (C=O); 77Se: 1469. IR, ν, cm–1: 3078 and 3056 
(CH), 1724 (C=O), 1579, 1213, 928, 745, 480. MS, m/z (%): 290 (M+2, 8), 
288 (M+, 63), 286 (3), 132 (10), 130 (100), 128 (1), 104 (3), 102 (43), 100 




5,6-Diphenyl[1,2,5]selenadiazolo[3,4-b]pyrazine 5c. Yellow solid, yield 
69 mg (64%), mp 261-263°С. Anal. calcd for С16Н10N4Se (337.24): С 
56.98, Н 2.99, N 16.61, Se 23.41. Found: C 57.12, H 3.18, N 16.42, Se 
23.50. NMR, δ, 1H: 7.37 (m, 4Н, Ph), 7.47 (m, 2Н, Ph), 7.60 (m, 4Н, Ph); 
13С: 128.3, 130.1, 130.3, 137.6, 156.5, 159.0; 77Se: 1452. IR, ν, cm–1: 
2922 and 2852 (CH), 1659, 1579, 1393, 1277, 1211, 876, 719, 697, 642, 
575, 509. MS, m/z (%): 340 (M+2, 11), 338 (M+, 50), 336 (18), 183 (28), 
129 (17), 105 (47). ESI-MS: found m/z 360.9960; calc. for C16Н10N4
78Se 
[M]+ 360.9963. 
Dibenzo[f,h][1,2,5]selenadiazolo[3,4-b]quinoxaline 5d. Dark red solid, 
yield 40.2 mg (67%), mp > 350 °С. Anal. calcd for С16Н8N4Se (335.22): С 
57.33, Н 2.41, N 16.71. Found: C 57.22, H 2.16, N 16.93. IR, ν, cm–1: 
3074 and 3056 (CH), 1601, 1450, 1330, 756, 721, 500. MS, m/z (%): 338 
(M+2, 14), 336 (M+, 92), 334 (33), 232 (10), 230 (100), 228 (1), 178 (66), 
176 (86), 80 (97). ESI-MS: found m/z 358.9825; calc. for C16Н8N4
78Se 
[M+Na]+ 358.9807. 
Acenaphtho[1,2-e][1,2,5]selenadiazolo[3,4-b]pyrazine 5e. Yellow solid, 
yield 77 mg (83%), mp > 350°С. Anal. calcd for С14Н6N4Se (309.18): С 
54.38, Н 1.96, N 18.12. Found: C 54.17; H 1.88; N 17.95. NMR, δ, 77Se 
(solid state): 1449. IR, ν, cm–1: 3077 and 3055 (CH), 1610, 1421, 1210, 
1110, 827, 775, 508. MS, m/z (%): 312 (M+2, 13), 310 (M+, 67), 308 (33), 
306 (13), 230 (15), 204 (100), 178 (30), 152 (33). ESI-MS: found m/z 
332.9652; calc. for C14Н6N4
78Se [M+Na]
+ 332.9650. 
General procedure for the reaction of 3,4-diamino-1,2,5-
selenadiazole 6 with 1,2-diketones in ethanol. A mixture of compound 
6 (49 mg, 0.3 mmol) and 1,2-diketone (1.5 ммоль) in EtOH (3 ml) was 
stirred at room temperature for 12 h, the precipitate was filtered off and 
washed with EtOH. Combined mother liquids were evaporated under 
reduced pressure. The residue was triturated with ether (2 ml), 
precipitate was filtered, washed by ether and dried. 
5-Methyl[1,2,5]selenadiazolo[3,4-b]pyrazine 5f. Dark red solid, yield 35 
mg (58%), mp 188-190°С. Anal. calcd for С5Н4N4Sе (199.07): С 30.17; Н 
2.03; N 28.14. Found: C 30.34; H 1.83; N 27.96. NMR (DMSO-d6), δ, 
1H: 
3.35 (s, 3Н, Me), 8.93 (s, 1Н, Ar); 13С: 23.1 (Me), 152.6(CH), 156.0, 
156.9, 160.6; 77Se: 1444; NMR 77Se (solid state) δ: 1454. IR, ν, cm–1: 
2982 and 2937 (СН), 1625, 1526, 1356, 1092, 712, 603, 512. MS, m/z 
(%): 202 (M+2, 13), 200 (M+, 100), 198 (57), 123 (4), 121 (79), 89 (4), 87 
(58), 85 (23), 82 (8), 80 (62), 69 (9), 67 (76), 65 (4). ESI-MS: found m/z 
222.9497; calc. for C5Н4N4
78Se [M+Na]
+ 222.9493. 
5,6-Dimethyl[1,2,5]selenadiazolo[3,4-b]pyrazine 5g. Yellow solid, yield 
58 mg (87%), mp 205-207°С. Anal. calcd for С6Н6N4Sе (213.10): С 
30.17; Н 2.03; N 28.14, Se 37.05. Found: C 30.34; H 1.83; N 27.96, Se 
37.15. NMR, (CDCl3) δ, 
1H: 2.78 (s, 6Н, Me); 13С: 24.0, 156.4, 160.3; 
77Se: 1426. IR, ν, cm–1: 2992 and 2956 (СН), 1479, 1395, 1254, 1168, 
1008, 880, 742, 692, 521, 469. MS, m/z (%): 216 (M+2, 1), 214 (M+, 39), 
212 (18), 123 (1), 121 (54), 80 (38), 69 (4), 67 (100), 65 (16). ESI-MS: 
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